Tag

CGC Archives - Carey Danis & Lowe

Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award

By | Actos, Pharmaceutical litigation, Uncategorized

actos_bladder_cancer_lawsuits_settlements_diabetes_litigation_fda_warningA California jury recently awarded a compensatory package of $6.5 million to a plaintiff in an Actos bladder cancer lawsuit. The case, Cooper v. Takeda, was heard over a two month period in a California Superior Court.

The jury arrived at their decision agreeing with Cooper’s claim that Takeda Pharmaceuticals, the manufacturer of the diabetes drug Actos, did not supply adequate safety information about the association between Actos and bladder cancer.

The plaintiff in the case, Jack Cooper, was presented with a $5 million compensatory award. The jury also bestowed a $1.5 million compensatory award upon Cooper’s spouse. Takeda did not have to pay punitive damages in the Actos case.

Carey Danis & Lowe Actos cancer lawyers believe that the jury’s ruling in Cooper’s Actos case delivers much optimism to individuals who have been injured by Actos, and have subsequently filed lawsuits against Takeda.

With the first case having been settled, Takeda faces more than 3,000 Actos lawsuits, according to a Thomson Reuters report. Cooper v. Takeda Pharmaceuticals America Inc. was heard in a California Superior Court in Los Angeles, case number CGC-12-518535.

Actos cancer lawyers at Carey Danis & Lowe are currently offering free legal evaluations of Actos cases. If you or someone you love has been injured by Actos, contact a Carey Danis & Lowe Actos cancer lawyer today by phone at 800.721.2519 or by submitting a legal claim form.